The aim of this observational study is to investigate the impact of body composition on the absorption, distribution, and metabolism of drugs. The primary question it seeks to answer is: Does body composition affect the absorption, distribution, and metabolism of drugs? By combining pharmacokinetic parameters and adverse drug reactions, the study will analyze differences in the metabolism of drugs under various body composition conditions. During the Phase I clinical trial, under the guidance of the researchers, subjects will use the non-invasive InBody S10 body composition analyzer to obtain body composition data, including but not limited to inorganic salts, muscle mass, lean body mass, body weight, and body fat percentage.
Study Type
OBSERVATIONAL
Enrollment
3,000
The Second Affiliated Hospital and Yuying Children's Hospital Affiliated to Wenzhou Medical University
Wenzhou, Zhejiang, China
RECRUITINGFat percentage (%)
Using a body composition analyzer:Inbody S10, non-invasively obtain the subject's body composition data。This instrument applies a very small electrical current to the body and obtains data on various body components based on the characteristics of different body compositions, including fat percentage (%)
Time frame: The day before using drug,and 1 to 4 days after using drug
Weight
Weight (kilogram) measured using a body weight scale.
Time frame: The day before using drug,and 1 to 4 days after using drug
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.